Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM1JF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,539
Award facts
- Contract value 100% obligated
- $17,539.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,539.29 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 30, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026.
AmerisourceBergen Drug Corp is a leading pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. Dupixent is a biologic immunosuppressant medication commonly used to treat moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, making it a specialized pharmaceutical commodity essential for military healthcare programs. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill complex medical supply requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices at both small and large transaction values.
Quick answers
Who was awarded contract SPE2DR26FM1JF?
SPE2DR26FM1JF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FM1JF worth?
The government has obligated $17,539 on SPE2DR26FM1JF.
Is contract SPE2DR26FM1JF an order under another contract?
Yes. SPE2DR26FM1JF is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM1JF competed?
The extent of competition for SPE2DR26FM1JF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award